Dayli Partners is a leading venture capital firm specializing in the bio industry. Comprised of bio healthcare experts, they strive to discover and invest in innovative scientific technologies to support the growth of advanced and global companies. With a competitive advantage based on quick investment decision-making, they secure deal sourcing and investor attraction capabilities.

Dayli Partners actively contributes to and maximizes investment value, aiming to enhance the value of companies even after they have gone public. Their strong points include actively enhancing the value of non-listed companies and achieving maximum investment value. They are committed to social contribution by promoting growth within the bio healthcare ecosystem, aligning the interests of the industry, companies, and investors.

Dayli Partners focuses on investing in companies that share their vision, and have proven their ability to source deals, make swift investment decisions, and form partnerships. With 30 funds, 3,426 billion KRW in VC AUM, and 603 billion KRW in PEF AUM, Dayli Partners is dedicated to investing in companies that share their dreams